Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Urogen Pharma (URGN) SEC Filings & 10K Form

Urogen Pharma logo
$19.44 -0.34 (-1.72%)
Closing price 04:00 PM Eastern
Extended Trading
$19.56 +0.11 (+0.59%)
As of 04:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Urogen Pharma SEC Filings

Export to Excel
DateFilerForm TypeView
08/14/2025
5:13 PM		RA CAPITAL MANAGEMENT, L.P. (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
08/13/2025
8:58 AM		Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025
3:30 PM		Paradigm Biocapital Advisors LP (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G
08/07/2025
7:01 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025
7:05 AM		Urogen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2025
6:29 AM		Schoenberg Mark (Reporting)
Urogen Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2025
6:23 AM		Smith Jason Drew (Reporting)
Urogen Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2025
6:02 PM		BlackRock, Inc. (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
07/16/2025
8:32 AM		Urogen Pharma (Filer)
Form ARS
07/15/2025
3:56 PM		Urogen Pharma (Filer)
Form DEF 14A
07/03/2025
3:16 PM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
10:38 AM		Cowen Financial Products LLC (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G
06/13/2025
7:00 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
8:14 AM		Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
8:27 AM		Schoenberg Mark (Reporting)
Urogen Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2025
6:19 PM		Monograph Capital Holdings Advisors, LLC (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13D/A
05/12/2025
8:02 AM		Adage Capital Management, L.P. (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
05/12/2025
7:06 AM		Urogen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2025
7:03 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
12:23 PM		MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
03/10/2025
3:32 PM		Urogen Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/10/2025
7:02 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
7:05 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
8:34 AM		Adage Capital Management, L.P. (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
02/05/2025
9:09 AM		MORGAN STANLEY (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
02/04/2025
10:49 AM		Barrett Elizabeth A. (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
10:51 AM		Smith Jason Drew (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
10:53 AM		Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
6:01 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
5:16 AM		Pontifax Management III G.P. Ltd. (0001726335) (Filed by)
Urogen Pharma (Subject)
Form SC 13D/A
11/14/2024
6:46 PM		Point72 Asset Management, L.P. (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/14/2024
4:46 PM		RA CAPITAL MANAGEMENT, L.P. (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/14/2024
11:04 AM		MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/14/2024
7:37 AM		COWEN AND COMPANY, LLC (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/14/2024
5:44 AM		RTW INVESTMENTS, LP (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/12/2024
8:30 AM		Adage Capital Management, L.P. (Filed by)
Urogen Pharma (Subject)
Form SC 13G
11/08/2024
1:17 PM		BlackRock, Inc. (Filed by)
Urogen Pharma (Subject)
Form SC 13G
11/06/2024
12:50 PM		MORGAN STANLEY (Filed by)
Urogen Pharma (Subject)
Form SC 13G
11/06/2024
7:01 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
7:04 AM		Urogen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
1:02 PM		BlackRock, Inc. (Filed by)
Urogen Pharma (Subject)
Form SC 13G
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.tc pixel

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
10/09/2024
3:21 PM		Degnan Chris (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/09/2024
3:22 PM		Degnan Chris (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
7:18 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
3:15 PM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
12:51 PM		Smith Jason Drew (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
12:54 PM		Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
12:50 PM		Kim Dong (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
6:16 AM		Schoenberg Mark (Reporting)
Urogen Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:URGN) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners
One tiny company just cracked Google’s $19B problem
Google, Microsoft, IBM… every major AI player will be forced to secure massive amounts of this material just t...
True Market Insiders | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
BREAKING: The House just passed 3 pro-crypto bills!
The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...
Crypto 101 Media | Sponsoredtc pixel
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...
Porter & Company | Sponsoredtc pixel
Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
Elon Musk’s New Technology
Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...
Paradigm Press | Sponsoredtc pixel
Could This Be the End of Retirement Worries?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel